Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne Wasylink

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Clinical Psychopharmacology|May 16, 2008
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-upChristopher Pittenger, Ben Kelmendi, Suzanne Wasylink, et al.
Psychopharmacology|March 27, 2003
Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorderVladimir Coric, Snezana Milanovic, Suzanne Wasylink, et al.
Frontiers in Behavioral Neuroscience|October 14, 2014
Resting state functional connectivity predicts neurofeedback responseDustin Scheinost, Teodora Stoica, Suzanne Wasylink, et al.
The Journal of Clinical Psychiatry|July 28, 2015
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trialChristopher Pittenger, Michael H Bloch, Suzanne Wasylink, et al.
Psychopharmacology|December 24, 2005
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorderDaniel L Lafleur, Christopher Pittenger, Ben Kelmendi, et al.
Biological Psychiatry|July 13, 2012
Effects of ketamine in treatment-refractory obsessive-compulsive disorderMichael H Bloch, Suzanne Wasylink, Angeli Landeros-Weisenberger, et al.
Biological Psychiatry|July 5, 2005
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trialVladimir Coric, Sarper Taskiran, Christopher Pittenger, et al.
Psychiatry Research|May 16, 2018
Developing image sets for inducing obsessive-compulsive checking symptomsHelena Brooks, Stephen A Kichuk, Thomas G Adams, et al.
Neuroimage|May 6, 2018
Time course of clinical change following neurofeedbackMariela Rance, Christopher Walsh, Denis G Sukhodolsky, et al.
Psychiatry Research|September 18, 2023
Neurofeedback for obsessive compulsive disorder: A randomized, double-blind trialMariela Rance, Zhiying Zhao, Brian Zaboski, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Clinical Psychopharmacology|May 16, 2008
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a series of 13 cases, with long-term follow-upChristopher Pittenger, Ben Kelmendi, Suzanne Wasylink, et al.
Psychopharmacology|March 27, 2003
Beneficial effects of the antiglutamatergic agent riluzole in a patient diagnosed with obsessive-compulsive disorder and major depressive disorderVladimir Coric, Snezana Milanovic, Suzanne Wasylink, et al.
Frontiers in Behavioral Neuroscience|October 14, 2014
Resting state functional connectivity predicts neurofeedback responseDustin Scheinost, Teodora Stoica, Suzanne Wasylink, et al.
The Journal of Clinical Psychiatry|July 28, 2015
Riluzole augmentation in treatment-refractory obsessive-compulsive disorder: a pilot randomized placebo-controlled trialChristopher Pittenger, Michael H Bloch, Suzanne Wasylink, et al.
Psychopharmacology|December 24, 2005
N-acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorderDaniel L Lafleur, Christopher Pittenger, Ben Kelmendi, et al.
Biological Psychiatry|July 13, 2012
Effects of ketamine in treatment-refractory obsessive-compulsive disorderMichael H Bloch, Suzanne Wasylink, Angeli Landeros-Weisenberger, et al.
Biological Psychiatry|July 5, 2005
Riluzole augmentation in treatment-resistant obsessive-compulsive disorder: an open-label trialVladimir Coric, Sarper Taskiran, Christopher Pittenger, et al.
Psychiatry Research|May 16, 2018
Developing image sets for inducing obsessive-compulsive checking symptomsHelena Brooks, Stephen A Kichuk, Thomas G Adams, et al.
Neuroimage|May 6, 2018
Time course of clinical change following neurofeedbackMariela Rance, Christopher Walsh, Denis G Sukhodolsky, et al.
Psychiatry Research|September 18, 2023
Neurofeedback for obsessive compulsive disorder: A randomized, double-blind trialMariela Rance, Zhiying Zhao, Brian Zaboski, et al.
Pageof 2